Shanghai Model Organisms Center, Inc. (SHA:688265)

Market Cap	2.40B +18.2%
Revenue (ttm)	432.55M +11.9%
Net Income	33.09M +79.6%
EPS	0.49 +128.9%
Shares Out	75.62M
PE Ratio	64.91
Forward PE	n/a
Dividend	0.13 (0.39%)
Ex-Dividend Date	n/a

Volume	897,430
Open	31.57
Previous Close	31.69
Day's Range	31.41 - 33.66
52-Week Range	27.80 - 72.72
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:688265

Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, and nervous system diseases, cardio-metabolic, autoimmune, and spontaneous tumor; and target humanized knockins, which includes tumor targets, immune ch...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 848
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688265

Financial Performance

In 2025, SHA:688265's revenue was 421.02 million, an increase of 10.44% compared to the previous year's 381.24 million. Earnings were 31.44 million, an increase of 383.97%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 23, 2026

Data Sources Report a data error